Advanced FDA Cleared Magstim Horizon 3.0 Transcranial Magnetic Stimulation Now Available in United Kingdom
07 juil. 2023 07h09 HE
|
Magstim EGI
WHITLAND, United Kingdom, July 07, 2023 (GLOBE NEWSWIRE) -- The advanced and FDA-cleared Magstim Horizon 3.0 transcranial magnetic stimulation (TMS) system is now UKCA registered and available for...
Developing New Treatments for Childhood Anxiety and OCD: Can Cognitive Control Help Kids Grow Out of Illness?
06 juin 2023 10h24 HE
|
Brain & Behavior Research Foundation
New York, June 06, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Developing New Treatments for Childhood Anxiety and OCD: Can Cognitive...
FDA Clears Magstim Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder
18 janv. 2023 13h05 HE
|
Magstim EGI
MINNEAPOLIS, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Magstim, a global leader in neuroscience research and Transcranial Magnetic Stimulation (TMS) solutions for mental health, announced today that the FDA...
neurocare group AG Announces Publication Confirming the Importance of Sleep for Effectiveness of Combined rTMS and CBT for OCD
21 nov. 2022 10h00 HE
|
neurocare group AG
MUNICH, Nov. 21, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
Chicago Behavior Center Utilizes Innovative Virtual Reality to Treat Obsessive-Compulsive Disorder and Anxiety Disorders
06 oct. 2022 16h01 HE
|
Compass Health Center (compasshealthcenter.net)
CHICAGO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Compass now offers Virtual Reality Care in its Adult Obsessive-Compulsive Disorder (OCD) and Complex Anxiety Programs across in-person locations and...
Identification of Symptom-Specific Brain Circuit Abnormalities in Obsessive-Compulsive Disorder
01 sept. 2022 08h00 HE
|
Brain & Behavior Research Foundation
New York, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Identification of Symptom-Specific Brain Circuit Abnormalities in...
VAGA Helps People Suffering with Poor Mental Health or Cognitive Decline Through Art Therapy
13 juin 2022 09h00 HE
|
Vaga
New York, June 13, 2022 (GLOBE NEWSWIRE) -- Mental health is a topic that has been under the spotlight in recent years, as people are realising that it is just as important as physical health and...
neurocare group AG Announces Recent Start of a Phase III Trial Examining the Cost-Effectiveness of TMS for Patients With Exposure Therapy-Resistant OCD
08 juin 2022 11h00 HE
|
neurocare group AG
MUNICH, June 08, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response - A Free Webinar from the Brain & Behavior Research Foundation
07 déc. 2021 09h00 HE
|
Brain & Behavior Research Foundation
New York, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response”...
BrainsWay’s Deep TMS Takes Center Stage at Clinical TMS Society Annual Poster Session
06 oct. 2020 09h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, Oct. 06, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive...